Publications & Reports

Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung.

Paul T King, Roleen Sharma, Kim M O'Sullivan, Judy Callaghan, Lovisa Dousha, Belinda Thomas, Saleela Ruwanpura, Steven Lim, Michael W Farmer, Barton R Jennings, Michaela Finsterbusch, Gavin Brooks, Stavros Selemidis, Gary P Anderson, Stephen R Holdsworth, Philip G Bardin
Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia. paul.king@monash.edu.

Abstract

Our aim was to investigate if deoxyribonuclease (DNase) 1 is a potential therapeutic agent to reduce pathogenic effects of cigarette smoke exposure in the lung. Cigarette smoke causes protease imbalance with excess production of proteases, which is a key process in the pathogenesis of emphysema. The mechanisms responsible for this effect are not well-defined. Our studies demonstrate both in vitro and in vivo that cigarette smoke significantly increases the expression of neutrophil and macrophage extracellular traps with coexpression of the pathogenic proteases, neutrophil elastase and matrix metalloproteinases 9 and 12. This response to cigarette smoke was significantly reduced by the addition of DNase 1, which also significantly decreased macrophage numbers and lung proteolysis. DNase 1, a treatment currently in clinical use, can diminish the pathogenic effects of cigarette smoke.

Publication

  • Journal: Scientific Reports
  • Published: 21/09/2017
  • Volume: 7
  • Issue: 1
  • Pagination: 12128